Voyager Therapeutics, Inc. (BMV:VYGR)
Mexico
· Delayed Price · Currency is MXN 60.00
0.00 (0.00%)
At close: May 7, 2025
Voyager Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 66.96 | 80 | 250.01 | 40.91 | 37.42 | 171.13 | Upgrade
|
| Revenue Growth (YoY) | -43.75% | -68.00% | 511.16% | 9.33% | -78.14% | 63.93% | Upgrade
|
| Cost of Revenue | 129.03 | 124.59 | 92.17 | 55.76 | 73.79 | 108.75 | Upgrade
|
| Gross Profit | -62.07 | -44.59 | 157.84 | -14.86 | -36.37 | 62.38 | Upgrade
|
| Selling, General & Admin | 36.95 | 35.92 | 35.82 | 30.98 | 37.25 | 34.99 | Upgrade
|
| Operating Expenses | 36.95 | 35.92 | 35.82 | 30.98 | 37.25 | 34.99 | Upgrade
|
| Operating Income | -99.02 | -80.51 | 122.01 | -45.84 | -73.62 | 27.38 | Upgrade
|
| Interest Expense | - | - | - | - | -0.39 | - | Upgrade
|
| Interest & Investment Income | 16.75 | 18.33 | 11.72 | 1.79 | - | 1.66 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.04 | 0.62 | 0 | 2.65 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -81.23 | -61.56 | 133.74 | -41.39 | -74.01 | 29.04 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | 2.81 | 7.7 | Upgrade
|
| Asset Writedown | -2.78 | -2.78 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | -5 | - | - | Upgrade
|
| Pretax Income | -84.01 | -64.34 | 133.74 | -46.39 | -71.2 | 36.74 | Upgrade
|
| Income Tax Expense | 0.69 | 0.67 | 1.41 | 0.02 | - | - | Upgrade
|
| Net Income | -84.69 | -65 | 132.33 | -46.41 | -71.2 | 36.74 | Upgrade
|
| Net Income to Common | -84.69 | -65 | 132.33 | -46.41 | -71.2 | 36.74 | Upgrade
|
| Shares Outstanding (Basic) | 58 | 58 | 43 | 38 | 38 | 37 | Upgrade
|
| Shares Outstanding (Diluted) | 58 | 58 | 45 | 38 | 38 | 37 | Upgrade
|
| Shares Change (YoY) | 22.98% | 29.39% | 16.20% | 1.83% | 0.86% | 4.04% | Upgrade
|
| EPS (Basic) | -1.46 | -1.13 | 3.08 | -1.21 | -1.89 | 0.99 | Upgrade
|
| EPS (Diluted) | -1.46 | -1.13 | 2.97 | -1.21 | -1.89 | 0.98 | Upgrade
|
| Free Cash Flow | -114.01 | -18.83 | 74.66 | -15 | -55.13 | -108.81 | Upgrade
|
| Free Cash Flow Per Share | -1.97 | -0.33 | 1.68 | -0.39 | -1.46 | -2.91 | Upgrade
|
| Gross Margin | -92.70% | -55.74% | 63.13% | -36.32% | -97.21% | 36.45% | Upgrade
|
| Operating Margin | -147.88% | -100.64% | 48.80% | -112.05% | -196.76% | 16.00% | Upgrade
|
| Profit Margin | -126.49% | -81.25% | 52.93% | -113.45% | -190.29% | 21.47% | Upgrade
|
| Free Cash Flow Margin | -170.27% | -23.54% | 29.86% | -36.67% | -147.36% | -63.59% | Upgrade
|
| EBITDA | -94.47 | -75.78 | 126.46 | -39.65 | -68.45 | 31.2 | Upgrade
|
| EBITDA Margin | -141.09% | -94.72% | 50.58% | -96.92% | -182.96% | 18.23% | Upgrade
|
| D&A For EBITDA | 4.55 | 4.73 | 4.44 | 6.19 | 5.17 | 3.82 | Upgrade
|
| EBIT | -99.02 | -80.51 | 122.01 | -45.84 | -73.62 | 27.38 | Upgrade
|
| EBIT Margin | -147.88% | -100.64% | 48.80% | -112.05% | -196.76% | 16.00% | Upgrade
|
| Effective Tax Rate | - | - | 1.05% | - | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.